| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access to radiotherapy and its association with cancer outcomes in a high-income country: Addressing the inequity in Canada
|
Chan, Jessica
|
|
|
141 |
C |
p. 48-55
|
artikel
|
| 2 |
A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy
|
Jackson, W.C.
|
|
|
141 |
C |
p. 101-107
|
artikel
|
| 3 |
A model-based patient selection tool to identify who may be at risk of exceeding dose tolerances during pancreatic SBRT
|
Magallon-Baro, Alba
|
|
|
141 |
C |
p. 116-122
|
artikel
|
| 4 |
Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion: Necessity to subclassify Barcelona Clinic Liver Cancer stage C
|
Kim, Yeon Joo
|
|
|
141 |
C |
p. 95-100
|
artikel
|
| 5 |
Comment on Long-term risks of secondary cancer for various whole and partial breast irradiation techniques
|
Ghaznavi, Hamid
|
|
|
141 |
C |
p. 331
|
artikel
|
| 6 |
Contents
|
|
|
|
141 |
C |
p. v-vii
|
artikel
|
| 7 |
Cost-effectiveness analysis of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced esophageal squamous cell carcinoma based on the NEOCRTEC5010 trial
|
Zhan, Mei
|
|
|
141 |
C |
p. 27-32
|
artikel
|
| 8 |
Critical review and quality-assessment of cost analyses in radiotherapy: How reliable are the data?
|
Defourny, Noémie
|
|
|
141 |
C |
p. 14-26
|
artikel
|
| 9 |
DNA damage enhancement by radiotherapy-activated hafnium oxide nanoparticles improves cGAS-STING pathway activation in human colorectal cancer cells
|
Marill, Julie
|
|
|
141 |
C |
p. 262-266
|
artikel
|
| 10 |
Dosimetric parameters predictive of nasolacrimal duct obstruction after carbon-ion radiotherapy for head and neck carcinoma
|
Kubo, Nobuteru
|
|
|
141 |
C |
p. 72-77
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
141 |
C |
p. ii
|
artikel
|
| 12 |
End-to-end empirical validation of dose accumulation in MRI-guided adaptive radiotherapy for prostate cancer using an anthropomorphic deformable pelvis phantom
|
Bohoudi, Omar
|
|
|
141 |
C |
p. 200-207
|
artikel
|
| 13 |
Erratum to “Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts” [Radiother. Oncol. 135 (2019) 74–77]
|
Putora, Paul Martin
|
|
|
141 |
C |
p. 332
|
artikel
|
| 14 |
Estimation of inter-fractional variations in interstitial multi-catheter breast brachytherapy using a hybrid treatment delivery system
|
Kallis, Karoline
|
|
|
141 |
C |
p. 312-320
|
artikel
|
| 15 |
ESTRO ACROP consensus guideline for target volume delineation in the setting of postmastectomy radiation therapy after implant-based immediate reconstruction for early stage breast cancer
|
Mutter, Robert W.
|
|
|
141 |
C |
p. 329-330
|
artikel
|
| 16 |
ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer
|
Ghadjar, Pirus
|
|
|
141 |
C |
p. 5-13
|
artikel
|
| 17 |
Evaluating the application of Pareto navigation guided automated radiotherapy treatment planning to prostate cancer
|
Wheeler, Philip A.
|
|
|
141 |
C |
p. 220-226
|
artikel
|
| 18 |
Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity
|
Spiegelberg, Linda
|
|
|
141 |
C |
p. 247-255
|
artikel
|
| 19 |
68Ga-DOTATATE PET/CT parameters predict response to peptide receptor radionuclide therapy in neuroendocrine tumours
|
Sharma, Rohini
|
|
|
141 |
C |
p. 108-115
|
artikel
|
| 20 |
[68Ga-]PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard – Implications for focal radiotherapy planning in primary prostate cancer
|
Bettermann, Alisa S.
|
|
|
141 |
C |
p. 214-219
|
artikel
|
| 21 |
Gleason pattern 5 is associated with an increased risk for metastasis following androgen deprivation therapy and radiation: An analysis of RTOG 9202 and 9902
|
Hamstra, Daniel A.
|
|
|
141 |
C |
p. 137-143
|
artikel
|
| 22 |
High efficacy of hypofractionated proton therapy with 4 fractions of 5 Gy as a boost to 50 Gy photon therapy for localized prostate cancer
|
Johansson, Silvia
|
|
|
141 |
C |
p. 164-173
|
artikel
|
| 23 |
How to evaluate agreement between quantitative measurements
|
Kopp-Schneider, Annette
|
|
|
141 |
C |
p. 321-326
|
artikel
|
| 24 |
Intrapulmonary percussive ventilation leading to 20-minutes breath-hold potentially useful for radiation treatments
|
Audag, Nicolas
|
|
|
141 |
C |
p. 292-295
|
artikel
|
| 25 |
Is adaptive treatment planning in multi-catheter interstitial breast brachytherapy necessary?
|
Kallis, Karoline
|
|
|
141 |
C |
p. 304-311
|
artikel
|
| 26 |
Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancer
|
Voskuilen, Charlotte S.
|
|
|
141 |
C |
p. 130-136
|
artikel
|
| 27 |
Low doses of ionizing radiation activate endothelial cells and induce angiogenesis in peritumoral tissues
|
Gil Marques, Filipa
|
|
|
141 |
C |
p. 256-261
|
artikel
|
| 28 |
Mechanically-assisted and non-invasive ventilation for radiation therapy: A safe technique to regularize and modulate internal tumour motion
|
Van Ooteghem, Geneviève
|
|
|
141 |
C |
p. 283-291
|
artikel
|
| 29 |
MRI assisted focal boost integrated with HDR monotherapy study in low and intermediate risk prostate cancer (MARS): Results from a phase II clinical trial
|
Alayed, Yasir
|
|
|
141 |
C |
p. 144-148
|
artikel
|
| 30 |
Multi-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: A global health initiative by the international consortium of total marrow irradiation
|
Zuro, Darren
|
|
|
141 |
C |
p. 275-282
|
artikel
|
| 31 |
NTCP model for postoperative complications and one-year mortality after trimodality treatment in oesophageal cancer
|
Thomas, Melissa
|
|
|
141 |
C |
p. 33-40
|
artikel
|
| 32 |
Patterns of recurrence after prostate bed radiotherapy
|
Brand, Douglas H.
|
|
|
141 |
C |
p. 174-180
|
artikel
|
| 33 |
Practical robustness evaluation in radiotherapy – A photon and proton-proof alternative to PTV-based plan evaluation
|
Korevaar, Erik W.
|
|
|
141 |
C |
p. 267-274
|
artikel
|
| 34 |
PSMA-PET guided dose-escalated volumetric arc therapy (VMAT) for newly diagnosed lymph node positive prostate cancer: Efficacy and toxicity outcomes at two years
|
Shakespeare, Thomas Philip
|
|
|
141 |
C |
p. 188-191
|
artikel
|
| 35 |
Quantitative imaging: Erring patterns in manual delineation of PET-imaged lung lesions
|
Yang, Fei
|
|
|
141 |
C |
p. 78-85
|
artikel
|
| 36 |
Radiomic signature: A novel magnetic resonance imaging-based prognostic biomarker in patients with skull base chordoma
|
Wei, Wei
|
|
|
141 |
C |
p. 239-246
|
artikel
|
| 37 |
Radiotherapy underutilisation and its impact on local control and survival in New South Wales, Australia
|
Merie, Roya
|
|
|
141 |
C |
p. 41-47
|
artikel
|
| 38 |
RBE-weighted dose in carbon ion therapy for ACC patients: Impact of the RBE model translation on treatment outcomes
|
Molinelli, Silvia
|
|
|
141 |
C |
p. 227-233
|
artikel
|
| 39 |
RBE-weighted doses in target volumes of chordoma and chondrosarcoma patients treated with carbon ion radiotherapy: Comparison of local effect models I and IV
|
Gillmann, Clarissa
|
|
|
141 |
C |
p. 234-238
|
artikel
|
| 40 |
Recommended ESTRO Core Curriculum for Radiation Oncology/Radiotherapy 4th edition
|
Benstead, Kim
|
|
|
141 |
C |
p. 1-4
|
artikel
|
| 41 |
Results of 15 Gy HDR-BT boost plus EBRT in intermediate-risk prostate cancer: Analysis of over 500 patients
|
Martell, K.
|
|
|
141 |
C |
p. 149-155
|
artikel
|
| 42 |
Risk factors for vertebral compression fracture after spine stereotactic body radiation therapy: Long-term results of a prospective phase 2 study
|
Mantel, Frederick
|
|
|
141 |
C |
p. 62-66
|
artikel
|
| 43 |
Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy
|
Henríquez López, Iván
|
|
|
141 |
C |
p. 156-163
|
artikel
|
| 44 |
Should risk-adapted delineation considered de-escalation of therapy? The ESTRO-ACROP radiation therapy guidelines after implant-based immediate reconstruction for early stage breast cancer
|
Kaidar-Person, Orit
|
|
|
141 |
C |
p. 327-328
|
artikel
|
| 45 |
Single vs multiple fraction palliative radiation therapy for bone metastases: Cumulative meta-analysis
|
Chow, Ronald
|
|
|
141 |
C |
p. 56-61
|
artikel
|
| 46 |
Synthetic MRI-aided multi-organ segmentation on male pelvic CT using cycle consistent deep attention network
|
Dong, Xue
|
|
|
141 |
C |
p. 192-199
|
artikel
|
| 47 |
The feasibility, safety and optimization of multiple prolonged breath-holds for radiotherapy
|
Parkes, Michael John
|
|
|
141 |
C |
p. 296-303
|
artikel
|
| 48 |
The impact of target dosimetry on patients’ locoregional recurrence in nasopharyngeal carcinoma: A propensity score-matched analysis
|
Wang, Jiazhou
|
|
|
141 |
C |
p. 67-71
|
artikel
|
| 49 |
Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference
|
Zamboglou, Constantinos
|
|
|
141 |
C |
p. 208-213
|
artikel
|
| 50 |
Validation of T2- and diffusion-weighted magnetic resonance imaging for mapping intra-prostatic tumour prior to focal boost dose-escalation using intensity-modulated radiotherapy (IMRT)
|
Alexander, E.J.
|
|
|
141 |
C |
p. 181-187
|
artikel
|
| 51 |
Validation study of the association between genetic variant of IL4 and severe radiation pneumonitis in lung cancer patients treated with radiation therapy
|
Tang, Yang
|
|
|
141 |
C |
p. 86-94
|
artikel
|
| 52 |
Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome
|
Mahantshetty, Umesh
|
|
|
141 |
C |
p. 123-129
|
artikel
|
Tijdschrift beschrijving